Quantbot Technologies LP Orasure Technologies Inc Transaction History

Quantbot Technologies LP

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$4.2 - $6.18 $91,471 - $134,594	21,779 New	21,779 $92,000
Q2 2023 Aug 08, 2023	SELL	$4.88 - $7.39 $116,202 - $175,970	-23,812 Reduced 63.23%	13,847 $69,000
Q1 2023 May 12, 2023	BUY	$4.66 - $6.52 $175,490 - $245,536	37,659 New	37,659 $227,000
Q3 2022 Nov 07, 2022	SELL	$2.72 - $4.61 $14,881 - $25,221	-5,471 Reduced 7.37%	68,755 $260,000
Q2 2022 Aug 09, 2022	BUY	$2.71 - $7.12 $201,152 - $528,489	74,226 New	74,226 $201,000
Q2 2021 Aug 12, 2021	SELL	$9.02 - $11.68 $11,969 - $15,499	-1,327 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$9.53 - $15.42 $39,730 - $64,285	-4,169 Reduced 75.86%	1,327 $15,000
Q4 2020 Feb 12, 2021	BUY	$10.35 - $15.94 $56,883 - $87,606	5,496 New	5,496 $58,000
Q4 2019 Feb 10, 2020	SELL	$7.21 - $8.89 $5,313 - $6,551	-737 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$6.57 - $9.46 $15,813 - $22,770	-2,407 Reduced 76.56%	737 $5,000
Q2 2019 Aug 13, 2019	BUY	$8.17 - $11.07 $25,686 - $34,804	3,144 New	3,144 $29,000
Q4 2018 Feb 13, 2019	SELL	$10.53 - $15.54 $233,081 - $343,977	-22,135 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$15.25 - $17.72 $108,183 - $125,705	7,094 Added 47.16%	22,135 $341,000
Q2 2018 Aug 13, 2018	SELL	$14.46 - $18.08 $154,013 - $192,570	-10,651 Reduced 41.46%	15,041 $247,000
Q1 2018 May 11, 2018	BUY	$16.77 - $22.04 $269,275 - $353,896	16,057 Added 166.65%	25,692 $433,000
Q4 2017 Feb 12, 2018	BUY	$13.44 - $22.81 $81,110 - $137,658	6,035 Added 167.64%	9,635 $181,000
Q3 2017 Nov 07, 2017	BUY	$19.97 - $22.74 $71,892 - $81,864	3,600	3,600 $81,000

202

65.5M

2.2K

5.1K

Ticker OSUR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 72,619,104
Market Cap $282M
Description
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rap...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.